Die IMI Research Agenda (Stand Juni 2011) bildet die Basis für die Themen der jeweiligen Ausschreibungen.
Die aktuelle IMI Forschungsagenda weist gegenüber der letzten Version von 2008 insbesondere folgende neue Elemente auf:
Erweiterung der bisherigen vier Säulen der Forschungsagenda (Safety, Efficacy, Knowledge Management, Education & Training) auf 7 vernetzte "Areas of Research Interest":
- Patients
- Diseases-Drug Efficacy
- Knowledge Management
- Strategies in R&D
- Development in Regulatory Framework
- Tools and Techniques
- Science Communication
Im Rahmen dieser “Areas of Research Interest” werden 10 „etablierte Forschungsprioritäten” und 8 neue "Key Research Priorities" definiert:
Established Key Research Priorities:
- Safety Sciences
- Increasing Practicability of Biomarkers and Biobanks
- Coping with Regulatory and Legal Hurdles
- Knowledge Management
- Science Communication
- Neuro-psychiatric Disorders/Brain Diseases
- Inflammatory and Immune-mediated Diseases
- Cancer
- Metabolic diseases including cardiovascular disease
- Infectious disease
New Key Research Priorities:
- Pharmacogenetics and Taxonomy of Human Disease
- Rare Diseases and Stratified Therapies
- Systems Approaches in Drug Research
- Beyond High-Throupghput Screening - Pharmacological Interactions at the Molecular level
- API Technology (Drug Compound Development)
- Advanced Formulations
- Stem Cells for Drug Development and Toxicity Screening
- Integration of Imaging Techniques into Drug Research